This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Sungwon Kim, Ph.D.
Head of Oligonucleotide R&D at ST Pharm
Speaker

Profile

Sungwon Kim, Ph.D., heads Oligonucleotide R&D at ST Pharm, with over 15 years of experience in process development and manufacturing of oligonucleotide APIs. While working at ST Pharm, he has expanded his capabilities in developing diverse types of oligonucleotides. Furthermore, he played an essential role in implementing microbial control for GMP production which require stringent control. Recently, he took the lead in establishing the process for developing and manufacturing long oligonucleotides, e.g., single guide RNA (sgRNA). He holds a Ph.D. in bioengineering.

Agenda Sessions

  • Process Development for sgRNA in CRISPR/Casx Therapeutics

    12:20pm